Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Bradley J. Blitvich is active.

Publication


Featured researches published by Bradley J. Blitvich.


Emerging Infectious Diseases | 2011

Probable Non–Vector-borne Transmission of Zika Virus, Colorado, USA

Brian D. Foy; Kevin C. Kobylinski; Joy L. Chilson Foy; Bradley J. Blitvich; Amelia Travassos da Rosa; Andrew D. Haddow; Robert S. Lanciotti; Robert B. Tesh

Clinical and serologic evidence indicate that 2 American scientists contracted Zika virus infections while working in Senegal in 2008. One of the scientists transmitted this arbovirus to his wife after his return home. Direct contact is implicated as the transmission route, most likely as a sexually transmitted infection.


Journal of Clinical Microbiology | 2003

Epitope-Blocking Enzyme-Linked Immunosorbent Assays for the Detection of Serum Antibodies to West Nile Virus in Multiple Avian Species

Bradley J. Blitvich; Nicole L. Marlenee; Roy A. Hall; Charles H. Calisher; Richard A. Bowen; John T. Roehrig; Nicholas Komar; Stanley A. Langevin; Barry J. Beaty

ABSTRACT We report the development of epitope-blocking enzyme-linked immunosorbent assays (ELISAs) for the rapid detection of serum antibodies to West Nile virus (WNV) in taxonomically diverse North American avian species. A panel of flavivirus-specific monoclonal antibodies (MAbs) was tested in blocking assays with serum samples from WNV-infected chickens and crows. Selected MAbs were further tested against serum samples from birds that represented 16 species and 10 families. Serum samples were collected from birds infected with WNV or Saint Louis encephalitis virus (SLEV) and from noninfected control birds. Serum samples from SLEV-infected birds were included in these experiments because WNV and SLEV are closely related antigenically, are maintained in similar transmission cycles, and have overlapping geographic distributions. The ELISA that utilized MAb 3.1112G potentially discriminated between WNV and SLEV infections, as all serum samples from WNV-infected birds and none from SLEV-infected birds were positive in this assay. Assays with MAbs 2B2 and 6B6C-1 readily detected serum antibodies in all birds infected with WNV and SLEV, respectively, and in most birds infected with the other virus. Two other MAbs partially discriminated between infections with these two viruses. Serum samples from most WNV-infected birds but no SLEV-infected birds were positive with MAb 3.67G, while almost all serum samples from SLEV-infected birds but few from WNV-infected birds were positive with MAb 6B5A-5. The blocking assays reported here provide a rapid, reliable, and inexpensive diagnostic and surveillance technique to monitor WNV activity in multiple avian species.


Journal of Virology | 2010

NS1′ of Flaviviruses in the Japanese Encephalitis Virus Serogroup Is a Product of Ribosomal Frameshifting and Plays a Role in Viral Neuroinvasiveness

Ezequiel Balmori Melian; Edward Hinzman; Tomoko Nagasaki; Andrew E. Firth; Norma M. Wills; Amanda Nouwens; Bradley J. Blitvich; J. Leung; Anneke Funk; John F. Atkins; Roy A. Hall; Alexander A. Khromykh

ABSTRACT Flavivirus NS1 is a nonstructural protein involved in virus replication and regulation of the innate immune response. Interestingly, a larger NS1-related protein, NS1′, is often detected during infection with the members of the Japanese encephalitis virus serogroup of flaviviruses. However, how NS1′ is made and what role it performs in the viral life cycle have not been determined. Here we provide experimental evidence that NS1′ is the product of a −1 ribosomal frameshift event that occurs at a conserved slippery heptanucleotide motif located near the beginning of the NS2A gene and is stimulated by a downstream RNA pseudoknot structure. Using site-directed mutagenesis of these sequence elements in an infectious clone of the Kunjin subtype of West Nile virus, we demonstrate that NS1′ plays a role in viral neuroinvasiveness.


Emerging Infectious Diseases | 2003

Serologic evidence of West Nile virus infection in horses, Coahuila State, Mexico.

Bradley J. Blitvich; Ildefonso Fernández-Salas; Juan F. Contreras-Cordero; Nicole L. Marlenee; José I. González-Rojas; Nicholas Komar; Duane J. Gubler; Charles H. Calisher; Barry J. Beaty

Serum samples were obtained from 24 horses in the State of Coahuila, Mexico, in December 2002. Antibodies to West Nile virus were detected by epitope-blocking enzyme-linked immunosorbent assay and confirmed by plaque reduction neutralization test in 15 (62.5%) horses. We report the first West Nile virus activity in northern Mexico.


Animal Health Research Reviews | 2008

Transmission dynamics and changing epidemiology of West Nile virus.

Bradley J. Blitvich

Abstract West Nile virus (WNV) is a flavivirus that is maintained in a bird–mosquito transmission cycle. Humans, horses and other non-avian vertebrates are usually incidental hosts, but evidence is accumulating that this might not always be the case. Historically, WNV has been associated with asymptomatic infections and sporadic disease outbreaks in humans and horses in Africa, Europe, Asia and Australia. However, since 1994, the virus has caused frequent outbreaks of severe neuroinvasive disease in humans and horses in Europe and the Mediterranean Basin. In 1999, WNV underwent a dramatic expansion of its geographic range, and was reported for the first time in the Western Hemisphere during an outbreak of human and equine encephalitis in New York City. The outbreak was accompanied by extensive and unprecedented avian mortality. Since then, WNV has dispersed across the Western Hemisphere and is now found throughout the USA, Canada, Mexico and the Caribbean, and parts of Central and South America. WNV has been responsible for >27,000 human cases, >25,000 equine cases and hundreds of thousands of avian deaths in the USA but, surprisingly, there have been only sparse reports of WNV disease in vertebrates in the Caribbean and Latin America. This review summarizes our current understanding of WNV with particular emphasis on its transmission dynamics and changing epidemiology.


Viruses | 2015

Insect-specific flaviviruses: a systematic review of their discovery, host range, mode of transmission, superinfection exclusion potential and genomic organization.

Bradley J. Blitvich; Andrew E. Firth

There has been a dramatic increase in the number of insect-specific flaviviruses (ISFs) discovered in the last decade. Historically, these viruses have generated limited interest due to their inability to infect vertebrate cells. This viewpoint has changed in recent years because some ISFs have been shown to enhance or suppress the replication of medically important flaviviruses in co-infected mosquito cells. Additionally, comparative studies between ISFs and medically important flaviviruses can provide a unique perspective as to why some flaviviruses possess the ability to infect and cause devastating disease in humans while others do not. ISFs have been isolated exclusively from mosquitoes in nature but the detection of ISF-like sequences in sandflies and chironomids indicates that they may also infect other dipterans. ISFs can be divided into two distinct phylogenetic groups. The first group currently consists of approximately 12 viruses and includes cell fusing agent virus, Kamiti River virus and Culex flavivirus. These viruses are phylogenetically distinct from all other known flaviviruses. The second group, which is apparently not monophyletic, currently consists of nine viruses and includes Chaoyang virus, Nounané virus and Lammi virus. These viruses phylogenetically affiliate with mosquito/vertebrate flaviviruses despite their apparent insect-restricted phenotype. This article provides a review of the discovery, host range, mode of transmission, superinfection exclusion ability and genomic organization of ISFs. This article also attempts to clarify the ISF nomenclature because some of these viruses have been assigned more than one name due to their simultaneous discoveries by independent research groups.


Journal of Clinical Microbiology | 2003

Epitope-blocking enzyme-linked immunosorbent assays for detection of west nile virus antibodies in domestic mammals

Bradley J. Blitvich; Richard A. Bowen; Nicole L. Marlenee; Roy A. Hall; Michel L. Bunning; Barry J. Beaty

ABSTRACT We evaluated the ability of epitope-blocking enzyme-linked immunosorbent assays (ELISAs) to detect West Nile virus (WNV) antibodies in domestic mammals. Sera were collected from experimentally infected horses, cats, and pigs at regular intervals and screened in ELISAs and plaque reduction neutralization tests. The diagnostic efficacies of these techniques were similar.


Emerging Infectious Diseases | 2003

Serologic Evidence of West Nile Virus Infection in Horses, Yucatan State, Mexico

Maria A. Loroño-Pino; Bradley J. Blitvich; Jose A. Farfan-Ale; Fernando I. Puerto; José M Blanco; Nicole L. Marlenee; Elsy P. Rosado-Paredes; Julian E. Garcia-Rejon; Duane J. Gubler; Charles H. Calisher; Barry J. Beaty

Serum samples were obtained from 252 horses in the State of Yucatan, Mexico, from July to October 2002. Antibodies to West Nile virus were detected by epitope-blocking enzyme-linked immunosorbent assays in three (1.2%) horses and confirmed by plaque reduction neutralization test. We report the first West Nile virus activity in the State of Yucatan.


Clinical and Vaccine Immunology | 2005

Persistence of antibodies to West Nile virus in naturally infected rock pigeons (Columba livia).

Samantha E. J. Gibbs; Douglas M. Hoffman; Lillian M. Stark; Nicole L. Marlenee; Bradley J. Blitvich; Barry J. Beaty; David E. Stallknecht

ABSTRACT Wild caught rock pigeons (Columba livia) with antibodies to West Nile virus were monitored for 15 months to determine antibody persistence and compare results of three serologic techniques. Antibodies persisted for the entire study as detected by epitope-blocking enzyme-linked immunosorbent assay and plaque reduction neutralization test. Maternal antibodies in squabs derived from seropositive birds persisted for an average of 27 days.


PLOS ONE | 2013

A new insect - specific flavivirus from northern Australia suppresses replication of West Nile virus and Murray Valley encephalitis virus in co-infected mosquito cells

Jody Hobson-Peters; Alice Wei Yee Yam; Jennifer Wei Fei Lu; Yin Xiang Setoh; Fiona J. May; Nina Kurucz; Susan Walsh; Natalie A. Prow; Steven Davis; Richard Weir; Lorna Melville; Neville Hunt; Richard I. Webb; Bradley J. Blitvich; Peter I Whelan; Roy A. Hall

Recent reports of a novel group of flaviviruses that replicate only in mosquitoes and appear to spread through insect populations via vertical transmission have emerged from around the globe. To date, there is no information on the presence or prevalence of these insect-specific flaviviruses (ISFs) in Australian mosquito species. To assess whether such viruses occur locally, we used reverse transcription-polymerase chain reaction (RT-PCR) and flavivirus universal primers that are specific to the NS5 gene to detect these viruses in mosquito pools collected from the Northern Territory. Of 94 pools of mosquitoes, 13 were RT-PCR positive, and of these, 6 flavivirus isolates were obtained by inoculation of mosquito cell culture. Sequence analysis of the NS5 gene revealed that these isolates are genetically and phylogenetically similar to ISFs reported from other parts of the world. The entire coding region of one isolate (designated 56) was sequenced and shown to have approximately 63.7% nucleotide identity and 66.6% amino acid identity with its closest known relative (Nakiwogo virus) indicating that the prototype Australian ISF represents a new species. All isolates were obtained from Coquillettidia xanthogaster mosquitoes. The new virus is tentatively named Palm Creek virus (PCV) after its place of isolation. We also demonstrated that prior infection of cultured mosquito cells with PCV suppressed subsequent replication of the medically significant West Nile and Murray Valley encephalitis viruses by 10–43 fold (1 to 1.63 log) at 48 hr post-infection, suggesting that superinfection exclusion can occur between ISFs and vertebrate-infecting flaviviruses despite their high level of genetic diversity. We also generated several monoclonal antibodies (mAbs) that are specific to the NS1 protein of PCV, and these represent the first ISF-specific mAbs reported to date.

Collaboration


Dive into the Bradley J. Blitvich's collaboration.

Top Co-Authors

Avatar

Barry J. Beaty

Colorado State University

View shared research outputs
Top Co-Authors

Avatar

Julian E. Garcia-Rejon

Universidad Autónoma de Yucatán

View shared research outputs
Top Co-Authors

Avatar

Jose A. Farfan-Ale

Universidad Autónoma de Yucatán

View shared research outputs
Top Co-Authors

Avatar

Maria A. Loroño-Pino

Universidad Autónoma de Yucatán

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ildefonso Fernández-Salas

Universidad Autónoma de Nuevo León

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lyric C. Bartholomay

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Carlos Machain-Williams

Universidad Autónoma de Yucatán

View shared research outputs
Top Co-Authors

Avatar

Carol D. Blair

Colorado State University

View shared research outputs
Researchain Logo
Decentralizing Knowledge